Stock 6452 PHARMALLY INTERNATIONAL HOLDING COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Pharmally International Holding Company Limited

Equities

6452

KYG7060F1019

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Pharmally International Holding Company Limited(TSEC:6452) dropped from S&P Global BMI Index
CI
Pharmally International Holding Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2020
CI
Pharmally International Holding Company Limited Reports Earnings Results for the Full Year Ended December 31, 2019
CI
Pharmally International Holding Company Limited Reports Earnings Results for the Third Quarter Ended September 30, 2019
CI
Pharmally International Holding Company Limited Reports Earnings Results for the Second Quarter Ended June 30, 2019
CI
Pharmally International Holding Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2019
CI
Pharmally International Holding Co Ltd Reports Earnings Results for the Full Year Ended December 31, 2018
CI
Pharmally International Holding Company Limited announced that it has received TWD 1.17 billion in funding
CI
Pharmally International Holding Company Limited completed the acquisition of PT. Biotis Prima Agrisindo.
CI
Pharmally International Holding Company Limited agreed to acquire PT. Biotis Prima Agrisindo for zero consideration.
CI
Pharmally International Holding Company Limited(TSEC:6452) added to MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index
CI
Pharmally International Holding Company Limited(TSEC:6452) added to S&P Global BMI Index
CI
Pharmally International Holding Company Limited's Equity Buyback announced on May 13, 2015 has expired.
CI
Pharmally International Holding Company Limited(TSEC:6452) added to Russell Global Index
CI
Pharmally International Holding Company Limited(TSEC:6452) added to Taiwan TAIEX Index
CI
Pharmally International Holding Company Limited announces an Equity Buyback for 2,000,000 shares, representing 3.08% for TWD 1,871.54 million.
CI
Pharmally International Holding Company Limited authorizes a Buyback Plan.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6452 Stock
  4. News Pharmally International Holding Company Limited